Long-term continuous subcutaneous infusion of ketoprofen combined with morphine: A safe and effective approach to cancer pain

Nora Maria Moselli, Mariaenrica Cruto, Paolo Massucco, Maurizio Savojardo, Felicino Debernardi

Research output: Contribution to journalArticlepeer-review

Abstract

According to international guidelines, nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids are the cornerstone drugs for cancer pain. In clinical practice, severe cancer pain often requires 3 step analgesics and alternative routes of administration, thus NSAIDs are usually abandoned. Our aim was to evaluate feasibility, safety, and efficacy of ketoprofen combined with opioids in long-term continuous subcutaneous infusion (CSI) for cancer pain in a prospective observational open-label pilot study. METHODS: Ketoprofen was added to morphine CSI in 172 consecutive patients (study group, SG). Concomitantly, 48 received opioids CSI without ketoprofen for contraindication to NSAIDs (control group, CG). CSI was delivered through a single-use elastomeric pump refilled weekly. Safety was evaluated according to the number of adverse events and their severity. The measures of efficacy were pain relief (NRS, Numerical Rating Scale), percentage of patients that needed to increase morphine dosage, and median relative increase between weeks 2 and 4. RESULTS: Toxicity typically attributable to NSAIDs were recorded in 4.1% of patients after 3 months of treatment and the combination of NSAIDs and corticosteroids seems not to influence the risk of gastrointestinal adverse effects. The local side effects related to the CSI regimen were negligible in both the groups. By the fourth week, pain was well controlled (NRS 0 to 2) in 80% of patients receiving ketoprofen compared with 46% of patients without ketoprofen (P

Original languageEnglish
Pages (from-to)267-274
Number of pages8
JournalClinical Journal of Pain
Volume26
Issue number4
DOIs
Publication statusPublished - May 2010

Keywords

  • Cancer pain
  • Continuous subcutaneous infusion
  • Ketoprofen
  • NSAIDs
  • Opioids

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Long-term continuous subcutaneous infusion of ketoprofen combined with morphine: A safe and effective approach to cancer pain'. Together they form a unique fingerprint.

Cite this